SEC Filing Analysis: Rafael Holdings, Inc. (RFL)

Executive Summary

• Trading Significance: Medium
• Key Takeaway: The CEO, Chairman, and President of Rafael Holdings, Howard S. Jonas, was awarded 75,000 restricted shares valued at approximately $94,000.
• Market Impact: Neutral. This transaction is a standard executive compensation grant, not an open-market purchase, and has a long vesting schedule, indicating a focus on long-term alignment rather than an immediate market signal.

Company Information

Field	Value
Company	Rafael Holdings, Inc.
Ticker Symbol	RFL
CIK	0001713863
Industry	Pharmaceutical Preparations

Insider Information

Field	Value
Name	JONAS HOWARD S
CIK	0001034247
Title/Position	Exec Chairman, CEO & President
Relationship	Director, Officer, 10% Owner

Transaction Details

Field	Value
Form Type	4
Transaction Date	2026-01-13
Transaction Code	A (Grant)
Security Type	Class B Common Stock, $.01 par value per share
Shares Involved	75,000
Price Per Share	$1.2485
Total Value	$93,637.50
Shares Owned After	332,840 (Directly)
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$93,637.50
% of Market Cap	0.16%
Shares Transacted	75,000
% of Shares Outstanding	N/A (Data not available)
Post-Transaction Ownership	14,075,655 Class B shares (Total Direct & Indirect)
Materiality Assessment	Moderate

Impact Evaluation

• Market Cap Context: For a company with a market capitalization of $60 million, this $93,638 grant represents 0.16% of its total value. This is a moderately sized grant, significant enough to be noteworthy but not transformative.
• Ownership Concentration: The insider already holds a very substantial position, exceeding 14 million shares through various direct and indirect entities. This grant modestly adds to that significant stake.
• Dilution Impact: As shares outstanding data is not available, a precise dilution calculation is not possible. However, as a grant, these 75,000 shares will eventually increase the total number of shares, causing minor dilution for existing shareholders upon vesting.
• Transaction Significance: The significance is rated 'Medium' because the grant was made to the highest-level executive (CEO/Chairman/President) and its value exceeds 0.1% of the company's market cap. The significance is tempered by the fact that it is a grant, not a cash purchase, and has a long vesting period.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: Restricted stock awards are a common form of executive compensation and do not reflect an insider's decision to deploy personal capital in the open market. The long vesting schedule further reinforces its nature as a long-term incentive rather than a short-term market signal.

Volume & Sentiment

• Expected Volume Impact: None. This is an issuance of shares from the company to the insider, not an open-market transaction.
• Sentiment Indicator: Neutral. The market generally views such grants as a standard cost of doing business to retain executive talent.

Investment Insights

Positive Market Indicators

• Executive Alignment: The grant aligns the CEO's financial interests with the company's long-term performance, as the shares only become valuable if the stock price is maintained or increases over the multi-year vesting period.

Risk Factors

• No immediate risk factors are apparent from this specific filing.

Key Takeaways

1. Executive Compensation: The filing documents a routine, albeit moderately sized, equity grant to the company's top executive.
2. Long-Term Incentive: The vesting schedule (starting in 2027 and ending in 2030) indicates this is an incentive for long-term performance, not a reaction to current events.
3. Moderate Materiality: The grant's value relative to the company's small market cap makes it more noteworthy than a similar grant at a larger corporation.

Additional Context

Transaction Notes

• Vesting Schedule: Per footnote 1, the 75,000 shares of restricted stock vest in four equal installments of 18,750 shares on January 13 of 2027, 2028, 2029, and 2030.